Financial Performance - The company's unaudited revenue for the six months ended October 31, 2025, was approximately HKD 128.7 million, a decrease of 5.4% compared to HKD 136.1 million in the same period last year[6]. - Profit attributable to the company's owners for the same period was approximately HKD 3.9 million, down 29.1% from HKD 5.5 million in the previous year[14]. - Revenue from the toy business decreased significantly by 23.2% to approximately HKD 82.8 million, compared to HKD 107.8 million in the previous year[7]. - Revenue from the laboratory equipment business increased by 62.2% to approximately HKD 45.9 million, up from HKD 28.3 million in the previous year, driven by a large-scale upgrade plan implemented by the Chinese government[7]. - Gross profit decreased by 8.0% to approximately HKD 21.8 million, with a gross margin of 16.9%, down from 17.4% in the previous year[9]. - Operating profit decreased to HKD 4,740 thousand, a decline of 29.0% from HKD 6,688 thousand in the previous year[22]. - Net profit for the period was HKD 3,850 thousand, down 15.5% from HKD 4,557 thousand in 2024[22]. - The net profit attributable to the company's owners was HKD 3,850,000, a decline of 30.6% from HKD 5,545,000 in the prior period[58]. Expenses and Costs - Selling and distribution expenses decreased by 7.9% to approximately HKD 5.8 million, reflecting a reduction in employee costs related to sales representatives[10]. - Administrative expenses decreased by 4.5% to approximately HKD 10.5 million, primarily due to reduced employee costs and other fixed indirect expenses[11]. - The group incurred total expenses of HKD 123,244,000, a slight decrease from HKD 129,746,000 in the previous period[53]. - The company incurred office operating lease expenses of HKD 720,000 for the six months ended October 31, 2025, compared to HKD 600,000 for the same period in 2024, reflecting an increase of 20%[71]. Cash Flow and Financial Position - The net cash flow from operating activities for the six months ended October 31, 2025, was HKD 3,934,000, a significant improvement from a net cash outflow of HKD 1,435,000 in the same period last year[33]. - Cash and cash equivalents at the end of the period increased to HKD 9,357,000 from HKD 2,297,000, marking a substantial rise of 308%[33]. - The company incurred a net cash outflow of HKD 1,397,000 from investing activities, which is an improvement compared to HKD 2,086,000 in the prior year[33]. - The company’s financing activities resulted in a net cash outflow of HKD 152,000, a significant reduction from HKD 1,499,000 in the previous period[33]. - The net cash inflow for the period was HKD 438,000, up from HKD 320,000 in the previous year, indicating improved cash flow management[74]. Assets and Liabilities - The company’s total assets increased to HKD 64,848 thousand as of October 31, 2025, compared to HKD 53,666 thousand as of April 30, 2025[25]. - Current liabilities rose to HKD 39,954 thousand, an increase from HKD 31,494 thousand in the previous period[27]. - Total liabilities were HKD 42,672,000, up from HKD 35,302,000 as of April 30, 2025[50]. - Total liabilities rose to HKD 20,690,000 as of October 31, 2025, from HKD 16,751,000 as of April 30, 2025, indicating a 23% increase[75]. - The accumulated losses decreased to HKD 73,342,000 from HKD 78,887,000, indicating a reduction of approximately 7.1%[31]. Investments and Projects - The company signed and completed a cooperation project with the Hubei Provincial Development and Reform Commission, with an order amount exceeding RMB 20 million[19]. - The company also won a national reform project in Hainan Province, with a booking amount of approximately RMB 19 million[19]. - The company plans to focus on laboratory renovation projects in Anhui, Shanxi, and Qinghai provinces in the next phase[19]. Market and Strategic Outlook - The company anticipates ongoing challenges due to U.S. tariffs and global geopolitical tensions, but remains committed to expanding its global product range and sales[17]. - The company has not entered into any foreign currency hedging financial instruments as of October 31, 2025[16]. - The Americas contributed HKD 42,755,000 to revenue, a significant decrease from HKD 69,803,000 in the prior year[52]. Shareholder Information - Basic and diluted earnings per share for the period were HKD 0.4, down from HKD 0.6 in 2024[24]. - The company did not declare or pay any dividends for the six months ended October 31, 2025[60]. - The company has not declared any interim dividends for the six months ended October 31, 2025[81]. Accounting and Financial Management - The company has not adopted new accounting standards that will have a significant impact on its financial performance for the current and prior periods[39]. - The financial risk management policies have remained unchanged since the last reporting period, indicating stability in the company's approach to managing financial risks[44]. - The company reported a net finance cost of HKD 5,000 for the period, compared to a net finance income of HKD 83,000 in the previous year[48][49]. Other Information - There were no significant events after the reporting date of October 31, 2025[83]. - No significant investments were held by the group other than investments in subsidiaries as of October 31, 2025[80]. - The company has not engaged in any purchase, sale, or redemption of its listed securities during the reporting period[79].
童园国际(03830) - 2026 - 中期财报